Fatty acids role in multiple sclerosis as "metabokines".

Area of Science:

• Neuroimmunology
• Metabolic pathways
• Autoimmune diseases

Background:

• Multiple sclerosis (MS) is an autoimmune neurological disease with genetic and environmental factors.
• Effective treatments for progressive MS are limited, necessitating exploration of new therapeutic targets.
• Fatty acids (FA) and their metabolism are increasingly recognized for their role in immune regulation and neurological health.

Purpose of the Study:

• To explore the intricate connection between fatty acids (FA) and multiple sclerosis (MS).
• To investigate the role of FA metabolism in autoimmunity and central nervous system (CNS) pathology.
• To identify novel therapeutic targets within FA metabolism for progressive MS.

Main Methods:

• Review of existing literature on FA metabolism and MS.
• Analysis of FA's impact on immune cell function and polarization.
• Examination of FA's role in blood-brain barrier integrity, CNS inflammation, and remyelination.

Main Results:

• Fatty acids (FA) act as "metabokines" modulating immune cell polarization, differentiation, and function.
• FA are crucial for maintaining blood-brain barrier integrity.
• FA contribute to chronic inflammation and degeneration in the CNS but are also vital for remyelination.

Conclusions:

• Fatty acid metabolism represents a promising area for novel therapeutic strategies in multiple sclerosis (MS).
• Further research is required to validate the therapeutic potential of targeting FA metabolism.
• Confirming the safety and efficacy of interventions targeting FA metabolism is essential for clinical application.